Seroquel XR 14-Day Sample Kit for Acute Bipolar Depression
RxNorm 1648647

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1648647 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Seroquel XR 14-Day Sample Kit for Acute Bipolar Depression.

The following semantic concepts and normalized strings are associated with this clinical entity:

PSN
Seroquel XR 14-Day Sample Kit for Acute Bipolar Depression
AUI:12815687
View
SY
Seroquel XR 14-Day Sample Kit for Acute Bipolar Depression
AUI:7236362
View
BPCK
{1 (24 HR quetiapine 200 mg Extended Release Oral Tablet [Seroquel]) / 11 (24 HR quetiapine 300 mg Extended Release Oral Tablet [Seroquel]) / 3 (24 HR quetiapine 50 mg Extended Release Oral Tablet [Seroquel]) } Pack [Seroquel XR 14-Day Sample Kit]
AUI:7236338
View
TMSY
{1 (24 HR QUEtiapine 200 mg Extended Release Oral Tablet [Seroquel]) / 11 (24 HR QUEtiapine 300 mg Extended Release Oral Tablet [Seroquel]) / 3 (24 HR QUEtiapine 50 mg Extended Release Oral Tablet [Seroquel]) } Pack [Seroquel XR 14-Day Sample Kit]
AUI:12814207
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

PSNPrescribable

Prescribable Name (PSN):
Seroquel XR 14-Day Sample Kit for Acute Bipolar Depression
(Atom ID: 12815687)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Seroquel XR 14-Day Sample Kit for Acute Bipolar Depression
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1648647
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12815687
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
1648647
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SYPrescribable

Synonym (SY):
Seroquel XR 14-Day Sample Kit for Acute Bipolar Depression
(Atom ID: 7236362)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Seroquel XR 14-Day Sample Kit for Acute Bipolar Depression
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1648647
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
7236362
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1648647
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
BPCKPrescribable

Brand Name Pack (BPCK):
{1 (24 HR quetiapine 200 mg Extended Release Oral Tablet [Seroquel]) / 11 (24 HR quetiapine 300 mg Extended Release Oral Tablet [Seroquel]) / 3 (24 HR quetiapine 50 mg Extended Release Oral Tablet [Seroquel]) } Pack [Seroquel XR 14-Day Sample Kit]
(Atom ID: 7236338)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{1 (24 HR quetiapine 200 MG Extended Release Oral Tablet [Seroquel]) / 11 (24 HR quetiapine 300 MG Extended Release Oral Tablet [Seroquel]) / 3 (24 HR quetiapine 50 MG Extended Release Oral Tablet [Seroquel]) } Pack [Seroquel XR 14-Day Sample Kit]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1648647
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
7236338
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
BPCK
Brand Name Pack ({# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name])
Source Code
1648647
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN HUMAN DRUG
US
Drug available for use in Humans
TMSYPrescribable

Tall Man Lettering Synonym (TMSY):
{1 (24 HR QUEtiapine 200 mg Extended Release Oral Tablet [Seroquel]) / 11 (24 HR QUEtiapine 300 mg Extended Release Oral Tablet [Seroquel]) / 3 (24 HR QUEtiapine 50 mg Extended Release Oral Tablet [Seroquel]) } Pack [Seroquel XR 14-Day Sample Kit]
(Atom ID: 12814207)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{1 (24 HR QUEtiapine 200 MG Extended Release Oral Tablet [Seroquel]) / 11 (24 HR QUEtiapine 300 MG Extended Release Oral Tablet [Seroquel]) / 3 (24 HR QUEtiapine 50 MG Extended Release Oral Tablet [Seroquel]) } Pack [Seroquel XR 14-Day Sample Kit]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1648647
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12814207
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
TMSY
Tall Man Lettering Synonym (Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.)
Source Code
1648647
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Quetiapine


Quetiapine tablets and extended-release (long-acting) tablets are used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Quetiapine tablets and extended-release tablets are also used alone or with other medications to treat episodes of mania (frenzied, abnormally excited or irritated mood) or depression in patients with bipolar disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). In addition, quetiapine tablets and extended-release tablets are used with other medications to prevent episodes of mania or depression in patients with bipolar disorder. Quetiapine extended-release tablets are also used along with other medications to treat depression. Quetiapine tablets may be used as part of a treatment program to treat bipolar disorder and schizophrenia in children and teenagers. Quetiapine is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
[Learn More]


* Please review the disclaimer below.